High FCF Margin Stocks in Health Care
Companies converting more than 10% of revenue into free cash flow, demonstrating efficient cash generation.
The information on this page is for informational purposes only and does not constitute investment advice, financial advice, or any recommendation. Billiver does not recommend buying, selling, or holding any security. Past performance is not indicative of future results.
Data may be delayed and accuracy is not guaranteed. All investment decisions are solely your responsibility. Verify information independently and consult a qualified financial advisor before investing. About · Methodology
60 Companies Meeting Criteria
Showing 1–50 of 60 companies, ranked by FCF Margin.
| # | Company | FCF Margin | Free Cash Flow |
|---|---|---|---|
| 1 | SYKStryker Corporation | 73.0% | $4.3B |
| 2 | DOCSDoximity | 38.7% | $184M |
| 3 | SGRYSurgery Partners, Inc. | 37.0% | $210M |
| 4 | RMDResMed | 32.3% | $1.7B |
| 5 | RSMDFResMed | 32.3% | $1.7B |
| 6 | LMATLeMaitre Vascular | 29.8% | $74M |
| 7 | MEDPMedpace | 27.0% | $682M |
| 8 | WAYWaystar Holding Corp | 25.8% | $283M |
| 9 | ISRGIntuitive Surgical | 24.8% | $2.5B |
| 10 | IDXXIdexx Laboratories | 24.6% | $1.1B |
| 11 | VCYTVeracyte, Inc. | 24.5% | $127M |
| 12 | HOLXHologic | 24.3% | $998M |
| 13 | HQYHealthEquity | 24.1% | $241M |
| 14 | DXCMDexcom | 23.1% | $1.1B |
| 15 | CERTCertara, Inc. | 22.6% | $95M |
| 16 | TMDXTransMedics Group, Inc. | 22.1% | $134M |
| 17 | EWEdwards Lifesciences | 22.0% | $1.3B |
| 18 | ILMNIllumina, Inc. | 21.4% | $931M |
| 19 | DHRDanaher Corporation | 21.4% | $5.3B |
| 20 | MTDMettler Toledo | 21.1% | $849M |
| 21 | TECHBio-Techne | 21.0% | $257M |
| 22 | IRMDIRADIMED CORP | 20.5% | $17M |
| 23 | TXG10x Genomics, Inc. | 20.2% | $130M |
| 24 | LNTHLantheus Holdings | 20.1% | $260M |
| 25 | GMEDGlobus Medical | 20.0% | $589M |
| 26 | HSTMHealthStream, Inc. | 19.6% | $60M |
| 27 | BSXBoston Scientific | 18.2% | $3.7B |
| 28 | ZBHZimmer Biomet | 17.9% | $1.5B |
| 29 | RVTYRevvity | 17.8% | $509M |
| 30 | WATWaters Corporation | 17.1% | $540M |
| 31 | EMBCEmbecta Corp. | 16.9% | $182M |
| 32 | ABTAbbott Laboratories | 16.7% | $7.4B |
| 33 | AAgilent Technologies | 16.6% | $1.2B |
| 34 | MDTMedtronic | 16.1% | $5.2B |
| 35 | WSTWest Pharmaceutical Services | 15.3% | $469M |
| 36 | PGNYProgyny | 14.9% | $192M |
| 37 | BIOBio-Rad Laboratories | 14.5% | $375M |
| 38 | MMSIMerit Medical Systems, Inc. | 14.2% | $216M |
| 39 | TMOThermo Fisher Scientific | 14.1% | $6.3B |
| 40 | PODDInsulet Corporation | 14.0% | $378M |
| 41 | MASIMasimo | 13.0% | $198M |
| 42 | CRLCharles River Laboratories | 12.9% | $518M |
| 43 | CHEChemed Corp. | 12.9% | $325M |
| 44 | SHCSotera Health | 12.8% | $149M |
| 45 | IQVIQVIA | 12.6% | $2.1B |
| 46 | LIVNLivaNova | 12.5% | $173M |
| 47 | PENPenumbra, Inc. | 12.5% | $175M |
| 48 | DGXQuest Diagnostics | 12.3% | $1.4B |
| 49 | TCMDTACTILE SYSTEMS TECHNOLOGY INC | 12.3% | $40M |
| 50 | BDXBecton Dickinson | 12.2% | $2.7B |
Understanding FCF Margin
An FCF margin above 10% means a company converts more than 10 cents of every revenue dollar into free cash. This signals capital-light operations and strong pricing power. Technology and pharmaceutical companies often lead in FCF margin due to low physical capital requirements.
FCF Margin > 10%
Results are based on SEC EDGAR filings. Companies with missing, unreliable, or extreme outlier values are excluded from screening.
Related Rankings
See the top companies ranked by these related metrics